The immediate catalyst for Cytodyn's leronlimab will be
The immediate catalyst for Cytodyn's leronlimab will be Compassionate Use "RESULTS". All EUAs are on the back burner IMO, for later. Leronlimab has Compassionate Use granted for the Philippines and Leronlimab has been shipped free, enough for 128 critical patients there, 4 shots each. Further, road cleared for enough LL for 100 patients per every hospital in the country for Compassionate Use. Future Compassionate Use vials of Leronlimab for the Philippines will be sold. There have been questions about Cytodyn charging money for Compassionate Use vials, and Nader made it clear, yes, they cannot "market", "promote", nor "advertises" product without an EUA, but they can charge for the drug. So, Philippines is already rolling and we expect India to be receiving Compassionate Use Leronlimab very very soon, may be free, may be sold, don't know that yet. Either way, things are looking bright for Cytodyn.
No order yet "THIS WEEK" as Nader stated? We're not sure! He said we would be aware of that order by reading about it in the next 8E or 10A or whatever that report is.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionary Hypertension Alerts in Apple Watch Ultra 3 Apple Inc. has recently launched the Apple Watch Ultra 3. This innovative device, now available for pre-order, is set to transform how users manage their health, particularly with its new blood pressure alert feature. FDA Approval: A Milestone for Apple Watch In an exciting move, the U.S. Food and Drug...
Continue Reading
Chartbeat Expands Services Through Strategic Acquisition Chartbeat, a prominent player in media operations software, has made significant strides in its mission to enhance its service offerings. The acquisition of FatTail, an innovative advertising revenue management platform, marks a pivotal moment in Chartbeat's journey. This strategic move, backed by Cuadrilla Capital,...
Continue Reading
Empower Pharmacy Recognized Among Fastest Growing Companies The recognition of Empower Pharmacy as No. 65 on the annual Inc. Regionals: Southwest list underscores its extraordinary journey in the healthcare sector. The companies that made this prestigious list experienced a median growth rate of an impressive 106 percent. This recognition not only highlights Empower’s...
Continue Reading
LightPath Technologies Secures Major Purchase Order LightPath Technologies, Inc. (NASDAQ: LPTH), a pioneer in the field of next-generation optics and imaging systems, has recently announced the receipt of a significant follow-on purchase order worth $22.1 million. This order, connected to the supply of advanced infrared camera systems, builds on their previous arrangement...
Continue Reading
Canaan Inc. Financial Performance Overview Total revenues for Canaan Inc. reached US$150.5 million, a remarkable increase of 104.4% year-over-year. This growth surpassed initial guidance and highlighted the company's resilience and effectiveness in meeting market demand. Notably, Bitcoin mining revenues surged to US$30.6 million, showcasing an impressive year-over-year...
Continue Reading
